Quart Barry D
SEC insider (Form 3/4/5 filer). CIK 0001384243. Director at Kiniksa Pharmaceuticals International, plc (KNSA) and 1 other issuer. 29 reported Form 4/5 transactions since Sep 2024; latest on Aug 19, 2026. Located in LONDON.
Companies Quart Barry D has filed insider reports for
- Kiniksa Pharmaceuticals International, plc (KNSA): Director
- Connect Biopharma Holdings Ltd (CNTB): Director, Officer, Chief Executive Officer
Quart Barry D
CIK: 0001384243
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Aug 19, 2026KNSA
Kiniksa Pharmaceuticals International, plc
GiftDirect2.6K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
12.2K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.8K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Units
2K shares- - Apr 28, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect13.1K shares at avg. $14.33$188K - Apr 28, 2026KNSA
Kiniksa Pharmaceuticals International, plc
SaleDirect13.1K shares at avg. $50.10$656K - Apr 6, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect6.9K shares at avg. $14.33$99K - Apr 6, 2026KNSA
Kiniksa Pharmaceuticals International, plc
SaleDirect6.9K shares at avg. $50.00$345K - Feb 12, 2026KNSA
Kiniksa Pharmaceuticals International, plc
SaleDirect2.7K shares at avg. $45.00$121K - Feb 12, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.7K shares at avg. $15.47$42K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 19, 2026 |  KNSA Kiniksa Pharmaceuticals International, plc | Gift | 2,600 | - | $0 | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 12,158 | - | - | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,799 | - | $0 | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Units | 2,026 | - | - | Direct |
| Apr 28, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 13,099 | $14.33 | $187,709 | Direct |
| Apr 28, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 13,099 | $50.10 | $656,260 | Direct |
| Apr 6, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 6,901 | $14.33 | $98,891 | Direct |
| Apr 6, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 6,901 | $50.00 | $345,050 | Direct |
| Feb 12, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 2,690 | $45.00 | $121,050 | Direct |
| Feb 12, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,690 | $15.47 | $41,614 | Direct |
1-10 of 29 transactions